Non-Hodgkin lymphoma is the 11th most common cause of cancer death in the UK, accounting for 3% of all cancer deaths (2017-2019).[1-4]
In females in the UK, non-Hodgkin lymphoma is the 11th most common cause of cancer death (3% of all female cancer deaths). In males in the UK, it is the 13th most common cause of cancer death (3% of all male cancer deaths).
44% of non-Hodgkin lymphoma deaths in the UK are in females, and 56% are in males (2017-2019).
Non-Hodgkin lymphoma mortality rates (European 
(AS) rates) in the UK are significantly lower in females than in males (2017-2019).
Non-Hodgkin lymphoma mortality rates (European (AS) rates) for persons are similar to the UK average in all the UK constituent countries.
For non-Hodgkin lymphoma, mortality rates do not vary between UK constituent nations however incidence rates do vary between the UK constituent nations.
Non-Hodgkin Lymphoma (C82-C86), Annual Average Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Persons Population, UK, 2017-2019
| England | Scotland | Wales | Northern Ireland | UK | ||
|---|---|---|---|---|---|---|
| Female | Deaths | 1,807 | 197 | 106 | 57 | 2,168 |
| Crude Rate | 6.4 | 7.1 | 6.7 | 6.0 | 6.4 | |
| AS Rate | 6.1 | 6.6 | 5.8 | 6.3 | 6.2 | |
| AS Rate - 95% LCL | 6.0 | 6.1 | 5.2 | 5.4 | 6.0 | |
| AS Rate - 95% UCL | 6.3 | 7.1 | 6.5 | 7.3 | 6.3 | |
| Male | Deaths | 2,310 | 219 | 151 | 61 | 2,741 |
| Crude Rate | 8.4 | 8.3 | 9.8 | 6.6 | 8.4 | |
| AS Rate | 9.8 | 9.6 | 10.4 | 8.7 | 9.8 | |
| AS Rate - 95% LCL | 9.6 | 8.9 | 9.4 | 7.5 | 9.6 | |
| AS Rate - 95% UCL | 10.1 | 10.3 | 11.3 | 10.0 | 10.0 | |
| Persons | Deaths | 4,116 | 416 | 257 | 118 | 4,908 |
| Crude Rate | 7.4 | 7.7 | 8.2 | 6.3 | 7.4 | |
| AS Rate | 7.8 | 7.9 | 7.8 | 7.4 | 7.8 | |
| AS Rate - 95% LCL | 7.6 | 7.5 | 7.3 | 6.6 | 7.7 | |
| AS Rate - 95% UCL | 7.9 | 8.3 | 8.4 | 8.1 | 7.9 | |
References
- England and Wales data were accessed from Nomis mortality statistics by underlying cause, sex and age, November 2021: Nomis mortality statistics by underlying cause, sex and age.
- Scotland data were provided by ISD Scotland on request, November 2021. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp(link is external).
- Northern Ireland data were provided by the Northern Ireland Cancer Registry on request, February 2022. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.
- Population data were published by the Office for National statistics, accessed July 2020. The data can be found here: Population estimates for the UK, England and Wales, Scotland and Northern Ireland, provisional: mid-2019.
About this data
Data is for UK, 2017-2019, C82-C86.
The term non-Hodgkin lymphoma describes a large group of lymphoma subtypes, which differ substantially in their cellular origin and clinical behaviour. The subtypes can be broadly divided into B-cell lymphomas, T-cell lymphomas, and lymphoproliferative disorders not otherwise specified. B-cell lymphomas can be further divided into five main types: diffuse large B-cell lymphoma, marginal zone lymphomas, follicular lymphoma, mantle cell lymphoma, and Burkitt lymphoma. It is important to recognise the variation between these subtypes when interpreting statistics on NHL as a whole. The Haematological Malignancy Research Network provides detailed incidence statistics for NHL subtypes.
